User profiles for Giorgia Massacci

Giorgia Massacci

University of Rome Tor Vergata
Verified email at moleculargenetics.uniroma2.it
Cited by 120

[HTML][HTML] The Cyclin-dependent kinase 1: more than a cell cycle regulator

G Massacci, L Perfetto, F Sacco - British Journal of Cancer, 2023 - nature.com
The Cyclin-dependent kinase 1, as a serine/threonine protein kinase, is more than a cell cycle
regulator as it was originally identified. During the last decade, it has been shown to carry …

Metabolic reprogramming of fibro/adipogenic progenitors facilitates muscle regeneration

…, LL Petrilli, G Maiolatesi, G Massacci… - Life science …, 2020 - life-science-alliance.org
In Duchenne muscular dystrophy (DMD), the absence of the dystrophin protein causes a
variety of poorly understood secondary effects. Notably, muscle fibers of dystrophic individuals …

[HTML][HTML] SCA-1 micro-heterogeneity in the fate decision of dystrophic fibro/adipogenic progenitors

…, C Fuoco, C Gargioli, E Giorda, G Massacci… - Cell Death & …, 2021 - nature.com
The term micro-heterogeneity refers to non-genetic cell to cell variability observed in a bell-shaped
distribution of the expression of a trait within a population. The contribution of micro-…

[HTML][HTML] Impact of FLT3-ITD location on cytarabine sensitivity in AML: a network-based approach

GM Pugliese, V Venafra, V Bica, G Massacci, S Latini… - Leukemia, 2023 - nature.com
TO THE EDITOR 25-30% of younger adults with newly diagnosed acute myeloid leukemia (AML)
carry internal tandem duplications (ITDs) in the FLT3 gene [1]. ITD mutations regularly …

[HTML][HTML] The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling

A Reggio, F Spada, M Rosina, G Massacci… - Scientific Reports, 2019 - nature.com
Fibro/Adipogenic Progenitors (FAPs) define a stem cell population playing a pro-regenerative
role after muscle damage. When removed from their natural niche, FAPs readily …

[HTML][HTML] A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients

G Massacci, V Venafra, S Latini, V Bica, GM Pugliese… - Leukemia, 2023 - nature.com
The insertion site of the internal tandem duplications (ITDs) in the FLT3 gene affects the
sensitivity to tyrosine kinase inhibitors (TKIs) therapy in acute myeloid leukemia (AML). Patients …

[HTML][HTML] Integrating patient-specific information into logic models of complex diseases: application to acute myeloid leukemia

…, I Rozzo, L Licata, L Perfetto, G Massacci… - Journal of Personalized …, 2021 - mdpi.com
High throughput technologies such as deep sequencing and proteomics are increasingly
becoming mainstream in clinical practice and support diagnosis and patient stratification. …

[HTML][HTML] Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction

S Latini, V Venafra, G Massacci, V Bica, S Graziosi… - Elife, 2024 - elifesciences.org
Currently, the identification of patient-specific therapies in cancer is mainly informed by
personalized genomic analysis. In the setting of acute myeloid leukemia (AML), patient-drug …

[HTML][HTML] A resource for the network representation of cell perturbations caused by SARS-CoV-2 infection

…, G Giuliani, S Latini, GM Pugliese, G Massacci… - Genes, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has caused more than 2.3 million
casualties worldwide and the lack of effective treatments is a major health concern. The …

[HTML][HTML] Combining mass spectrometry-based phosphoproteomics with a network-based approach to reveal flt3-dependent mechanisms of chemoresistance

GM Pugliese, S Latini, G Massacci, L Perfetto, F Sacco - Proteomes, 2021 - mdpi.com
FLT3 mutations are the most frequently identified genetic alterations in acute myeloid
leukemia (AML) and are associated with poor clinical outcome, relapse and chemotherapeutic …